Home » Topics » Regulatory » Patents

Patents
RSS

BASF patents new series with endothelin-antagonist activity

Oct. 1, 1998

Novel erythromycins from HMR useful for Gram-positive and other infections

Oct. 1, 1998

Piperazines as inhibitors of MMPs and/or TNF-alpha prepared at Fujisawa

Oct. 1, 1998

Yamanouchi and Merck KGaA work together to develop Na+/H+ exchange inhibitors

Sep. 30, 1998

Pyrrole antiviral agents prepared and evaluated at Rhone-Poulenc Rorer

Sep. 30, 1998

Dual LTD4 antagonists/histamine release inhibitors in development at Daiichi

Sep. 30, 1998

Antisecretory benzodiazepines for GI disorders designed at Zeria

Sep. 30, 1998

Sanofi describes new series acting on vasopressin and/or oxytocin receptors

Sep. 30, 1998

Peptide analgesics described by Asahi Glass

Sep. 30, 1998

Neurotrophic/neuroprotective compounds claimed by Sanofi

Sep. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...